BACKGROUND: In patients with ST-elevation myocardial infarction treated with fibrinolysis,
routine early percutaneous coronary intervention (r-PCI) improves clinical outcomes at 30 …

Results The RESCUE I trial did not involve the use of stenting or glycoprotein IIb/IIIa
inhibitors, and patients with previous MI were excluded. The recruitment rate in MERLIN was …

Background: Fibrinolysis remains an important treatment for ST‐elevation myocardial
infarction, but fails to achieve adequate reperfusion in a significant proportion of …

Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy for
patients with ST-segment elevation myocardial infarction (STEMI) if it can be performed in a …

Most cases of acute myocardial infarction are caused by disruption of an atherosclerotic
plaque followed by coronary thrombosis (1). In ST-elevation myocardial infarction (STEMI) …

fraction (EF) up to 6 weeks. Simoons et al4 randomized 367 patients with AMI treated with
rTPA to an invasive strategy with angioplasty or a noninvasive strategy and noted the clinical …

Recently, primary percutaneous coronary intervention (PCI) is the best option for reperfusion
in STEMI patients, in clinical trials has lower rates of reinfarction, stroke and mortality than …

Background: Randomized trials comparing primary angioplasty and in-hospital fibrinolysis in
acute myocardial infarction (AMI) have shown an advantage for primary angioplasty. The …

The decision over whether to treat acute myocardial infarction (AMI) with a balloon or
infusion of fibrinolytics remains controversial. During the past few years profound changes in …

Reperfusion therapy with pharmacologic fibrinolysis has provided striking reductions in
mortality following acute ST-elevation myocardial infarction (STEMI). Nevertheless, the …